Pompe Disease Registry Protocol

Summary

The Pompe Registry is a global, multicenter, international, longitudinal, observational, and voluntary program for patients with Pompe disease, designed to track the disease's natural history and outcomes in patients, both treated and not. Data from the Registry are also used to fulfill various global regulatory commitments, to support product development/reimbursement, and for other research and non-research related purposes.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

• Glycogen Storage Disease Type II
• Pompe Disease

Eligibility basics and study details

Study type

Observational

Phase

Not applicable

Ages

Any age

Sex

All

Healthy volunteers

Not accepted

Sponsor

Genzyme, a Sanofi Company

Last updated on ClinicalTrials.gov

October 28, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites